ANTARES PHARMA INC (ATRS)
US0366421065 - Common Stock
| 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | 2017 (2017-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 46.29M | 56.20M | -2.03M | -6.52M | -16.74M | |||
| Depreciation Amortization | 3.90M | 2.63M | 2.56M | 2.72M | 2.10M | |||
| Income Taxes - Deferred | 13.94M | -46.98M | N/A | N/A | N/A | |||
| Change In Working Capital | 1.59M | 470.00K | -18.36M | -6.81M | -11.63M | |||
| Interest Paid | 2.74M | 3.54M | 3.03M | N/A | N/A | |||
| Taxes Paid | 1.78M | N/A | N/A | N/A | N/A | |||
| Other non cash items | -29.11M | 9.01M | 7.21M | -6.72M | 3.17M | |||
| OPERATING CASH FLOW | 36.62M | 21.32M | -10.62M | -17.32M | -23.09M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -20.43M | -14.62M | -2.35M | -890.00K | -1.27M | |||
| Other Investing Activity | 16.58M | 22.78M | -17.65M | 12.50M | -3.06M | |||
| INVESTING CASH FLOW | -3.85M | 8.17M | -20.00M | 11.61M | -4.33M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -20.00M | 0.00 | 15.00M | 0.00 | 25.00M | |||
| Stock Issued/Repurchased | 5.18M | 1.81M | 12.19M | 7.59M | 1.82M | |||
| Other Financing Activity | -5.17M | -1.37M | -1.27M | -540.00K | -540.00K | |||
| FINANCING CASH FLOW | -19.99M | 450.00K | 25.92M | 7.05M | 26.27M | |||
| Exchange Rate Effect | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| CHANGE IN CASH | 12.78M | 29.94M | -4.70M | 1.34M | -1.15M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 36.62M | 21.32M | -10.62M | -17.32M | -23.09M | |||
| Capital Expenditure | -20.43M | -14.62M | -2.35M | -890.00K | -1.27M | |||
| FREE CASH FLOW | 16.19M | 6.70M | -12.97M | -18.21M | -24.36M | |||
All data in USD